Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-22

Clinical Trial Update: Efficacy, Safety and Acceptability of Ivermectin ODT in PSAC [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the efficacy, safety, and acceptability of an ivermectin orally disintegrating tablet in preschool-aged children for Trichuriasis, Asca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ivermectin ODT (ivermectin)

Snippet

Sponsor: Jennifer Keiser | Conditions: Trichuriasis, Ascariasis | Phase 2 | Status: COMPLETED | Results posted: 2025-09-22